Infuvite Adult

INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.

The physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy.

• •INFUVITE ADULT is a combination product that contains the following vitamins: ascorbic acid, vitamin A, vitamin D, thiamine, riboflavin, pyridoxine, niacinamide, dexpanthenol, vitamin E, vitamin K₁, folic acid, biotin, and vitamin B₁₂ (
  2.1 Important Dosage Instructions

  INFUVITE ADULT is a combination product that contains the following vitamins: ascorbic acid, vitamin A, vitamin D, thiamine, riboflavin, pyridoxine, niacinamide, dexpanthenol, vitamin E, vitamin K₁, folic acid, biotin, and vitamin B₁₂

  .

  INFUVITE ADULT is supplied as a single dose or as a pharmacy bulk package for intravenous use intended for administration by intravenous infusion after dilution.

  INFUVITE ADULT

  Single Dose:

  • •Provides one daily dose of 10 mL (5 mL of Vial 1 plus 5 mL of Vial 2) which must be diluted prior to intravenous administration
    [see Dosage and Administration ]
    .

  INFUVITE ADULT

  Pharmacy

  Bulk Package:

  • •Provides ten 10 mL daily doses when the content of vial 1 is transferred into the content of vial 2. One 10 mL dose is then added directly to intravenous fluid. Pharmacy bulk package of INFUVITE ADULT is intended for dispensing of single doses to multiple patients in a pharmacy admixture program and is restricted to the preparation of admixtures for infusion
    [see Dosage and Administration (
    2.2
    )].

  Patients with multiple vitamin deficiencies or with increased vitamin requirements may need multiple daily dosages as indicated. Some patients do not maintain adequate levels of certain vitamins when this formulation in recommended amounts is the only source of vitamins.
  )
• •INFUVITE ADULT is for administration by intravenous infusion after dilution (
  2.1 Important Dosage Instructions

  INFUVITE ADULT is a combination product that contains the following vitamins: ascorbic acid, vitamin A, vitamin D, thiamine, riboflavin, pyridoxine, niacinamide, dexpanthenol, vitamin E, vitamin K₁, folic acid, biotin, and vitamin B₁₂

  .

  INFUVITE ADULT is supplied as a single dose or as a pharmacy bulk package for intravenous use intended for administration by intravenous infusion after dilution.

  INFUVITE ADULT

  Single Dose:

  • •Provides one daily dose of 10 mL (5 mL of Vial 1 plus 5 mL of Vial 2) which must be diluted prior to intravenous administration
    [see Dosage and Administration ]
    .

  INFUVITE ADULT

  Pharmacy

  Bulk Package:

  • •Provides ten 10 mL daily doses when the content of vial 1 is transferred into the content of vial 2. One 10 mL dose is then added directly to intravenous fluid. Pharmacy bulk package of INFUVITE ADULT is intended for dispensing of single doses to multiple patients in a pharmacy admixture program and is restricted to the preparation of admixtures for infusion
    [see Dosage and Administration (
    2.2
    )].

  Patients with multiple vitamin deficiencies or with increased vitamin requirements may need multiple daily dosages as indicated. Some patients do not maintain adequate levels of certain vitamins when this formulation in recommended amounts is the only source of vitamins.
  )
• •Recommended daily dosage is 10 mL (
  2.1 Important Dosage Instructions

  INFUVITE ADULT is a combination product that contains the following vitamins: ascorbic acid, vitamin A, vitamin D, thiamine, riboflavin, pyridoxine, niacinamide, dexpanthenol, vitamin E, vitamin K₁, folic acid, biotin, and vitamin B₁₂

  .

  INFUVITE ADULT is supplied as a single dose or as a pharmacy bulk package for intravenous use intended for administration by intravenous infusion after dilution.

  INFUVITE ADULT

  Single Dose:

  • •Provides one daily dose of 10 mL (5 mL of Vial 1 plus 5 mL of Vial 2) which must be diluted prior to intravenous administration
    [see Dosage and Administration ]
    .

  INFUVITE ADULT

  Pharmacy

  Bulk Package:

  • •Provides ten 10 mL daily doses when the content of vial 1 is transferred into the content of vial 2. One 10 mL dose is then added directly to intravenous fluid. Pharmacy bulk package of INFUVITE ADULT is intended for dispensing of single doses to multiple patients in a pharmacy admixture program and is restricted to the preparation of admixtures for infusion
    [see Dosage and Administration (
    2.2
    )].

  Patients with multiple vitamin deficiencies or with increased vitamin requirements may need multiple daily dosages as indicated. Some patients do not maintain adequate levels of certain vitamins when this formulation in recommended amounts is the only source of vitamins.
  )
• •INFUVITE ADULT is supplied as a single dose and as a pharmacy bulk package.
• o
  Single Dose
  : Add one daily dose of 10 mL (5 mL from Vial 1 and 5 mL from Vial 2) to not less than 500 mL, and preferably 1000 mL, of intravenous dextrose, saline or similar infusion solutions. (
  2.2 Preparation and Administration Instructions

  Do not administer INFUVITE ADULT as a direct, undiluted intravenous injection as it may cause dizziness, faintness, and possible tissue irritation

  .

  INFUVITE ADULT

  Single Dose

  :

  • •Use only in a suitable work area such as a laminar flow hood (or an equivalent clean air compounding area).
  • •Add 5 mL of Vial 1 and 5 mL of Vial 2 to at least 500 mL to 1000 mL, of intravenous dextrose or saline solutions.
  • •Discard unused portion.
  • •Visually inspect for particulate matter and discoloration prior to administration.
  • •After INFUVITE ADULT is diluted in an intravenous infusion, refrigerate the resulting solution unless it is to be used immediately, and use the solution within 24 hours after dilution.
  • •Minimize exposure to light because some of the vitamins in INFUVITE ADULT, particularly A, D and riboflavin, are light sensitive.

  INFUVITE ADULT

  Pharmacy Bulk Package

  :

  • •Use only in a suitable work area such as a laminar flow hood (or an equivalent clean air compounding area).
  • •Transfer the contents of Vial 1 into the contents of Vial 2 to provide ten 10 mL single doses.
  • •Each bulk vial closure shall be penetrated only one time with a suitable sterile transfer device or dispensing set that allows measured dispensing of the contents.
  • •Once the closure system has been penetrated, complete dispensing from the pharmacy bulk vial should be completed within 4 hours. The mixed solution may be refrigerated and stored for up to 4 hours.
  • •Discard unused portion.
  • •Visually inspect for particulate matter and discoloration prior to administration.
  • •One daily 10 mL dose should be added directly to at least 500 mL to 1000 mL, of intravenous dextrose, saline or similar infusion solutions.
  • •After INFUVITE ADULT is diluted in an intravenous infusion, refrigerate the resulting solution unless it is to be used immediately, and use the solution within 24 hours after dilution.
  • •Minimize exposure to light because some of the vitamins in INFUVITE ADULT, particularly A, D and riboflavin, are light sensitive.
  )
• o
  Pharmacy Bulk Package
  : Add the contents of Vial 1 to the contents of Vial 2. This provides ten 10 mL daily doses. Take 10 mL from Vial 2 and add to not less than 500 mL, and preferably 1000 mL, of intravenous dextrose, saline or similar infusion solutions. (
  2.2 Preparation and Administration Instructions

  Do not administer INFUVITE ADULT as a direct, undiluted intravenous injection as it may cause dizziness, faintness, and possible tissue irritation

  .

  INFUVITE ADULT

  Single Dose

  :

  • •Use only in a suitable work area such as a laminar flow hood (or an equivalent clean air compounding area).
  • •Add 5 mL of Vial 1 and 5 mL of Vial 2 to at least 500 mL to 1000 mL, of intravenous dextrose or saline solutions.
  • •Discard unused portion.
  • •Visually inspect for particulate matter and discoloration prior to administration.
  • •After INFUVITE ADULT is diluted in an intravenous infusion, refrigerate the resulting solution unless it is to be used immediately, and use the solution within 24 hours after dilution.
  • •Minimize exposure to light because some of the vitamins in INFUVITE ADULT, particularly A, D and riboflavin, are light sensitive.

  INFUVITE ADULT

  Pharmacy Bulk Package

  :

  • •Use only in a suitable work area such as a laminar flow hood (or an equivalent clean air compounding area).
  • •Transfer the contents of Vial 1 into the contents of Vial 2 to provide ten 10 mL single doses.
  • •Each bulk vial closure shall be penetrated only one time with a suitable sterile transfer device or dispensing set that allows measured dispensing of the contents.
  • •Once the closure system has been penetrated, complete dispensing from the pharmacy bulk vial should be completed within 4 hours. The mixed solution may be refrigerated and stored for up to 4 hours.
  • •Discard unused portion.
  • •Visually inspect for particulate matter and discoloration prior to administration.
  • •One daily 10 mL dose should be added directly to at least 500 mL to 1000 mL, of intravenous dextrose, saline or similar infusion solutions.
  • •After INFUVITE ADULT is diluted in an intravenous infusion, refrigerate the resulting solution unless it is to be used immediately, and use the solution within 24 hours after dilution.
  • •Minimize exposure to light because some of the vitamins in INFUVITE ADULT, particularly A, D and riboflavin, are light sensitive.
  )
• •After dilution in an intravenous infusion, refrigerate resulting solution unless used immediately. Use solution within 24 hours after dilution (
  2.2 Preparation and Administration Instructions

  Do not administer INFUVITE ADULT as a direct, undiluted intravenous injection as it may cause dizziness, faintness, and possible tissue irritation

  .

  INFUVITE ADULT

  Single Dose

  :

  • •Use only in a suitable work area such as a laminar flow hood (or an equivalent clean air compounding area).
  • •Add 5 mL of Vial 1 and 5 mL of Vial 2 to at least 500 mL to 1000 mL, of intravenous dextrose or saline solutions.
  • •Discard unused portion.
  • •Visually inspect for particulate matter and discoloration prior to administration.
  • •After INFUVITE ADULT is diluted in an intravenous infusion, refrigerate the resulting solution unless it is to be used immediately, and use the solution within 24 hours after dilution.
  • •Minimize exposure to light because some of the vitamins in INFUVITE ADULT, particularly A, D and riboflavin, are light sensitive.

  INFUVITE ADULT

  Pharmacy Bulk Package

  :

  • •Use only in a suitable work area such as a laminar flow hood (or an equivalent clean air compounding area).
  • •Transfer the contents of Vial 1 into the contents of Vial 2 to provide ten 10 mL single doses.
  • •Each bulk vial closure shall be penetrated only one time with a suitable sterile transfer device or dispensing set that allows measured dispensing of the contents.
  • •Once the closure system has been penetrated, complete dispensing from the pharmacy bulk vial should be completed within 4 hours. The mixed solution may be refrigerated and stored for up to 4 hours.
  • •Discard unused portion.
  • •Visually inspect for particulate matter and discoloration prior to administration.
  • •One daily 10 mL dose should be added directly to at least 500 mL to 1000 mL, of intravenous dextrose, saline or similar infusion solutions.
  • •After INFUVITE ADULT is diluted in an intravenous infusion, refrigerate the resulting solution unless it is to be used immediately, and use the solution within 24 hours after dilution.
  • •Minimize exposure to light because some of the vitamins in INFUVITE ADULT, particularly A, D and riboflavin, are light sensitive.
  )
• •Monitor blood vitamin concentrations (
  2.3 Monitoring Vitamin Blood Levels

  Blood vitamin concentrations should be monitored to ensure maintenance of adequate levels, particularly in patients receiving parenteral multivitamins as the only source of vitamins for long periods of time.
  )
• •See Full Prescribing Information for drug incompatibilities (
  2.4 Drug Incompatibilities

  • •INFUVITE ADULT is not physically compatible with moderately alkaline solutions such as a sodium bicarbonate solution and other alkaline drugs such as acetazolamide sodium, aminophylline, ampicillin sodium, tetracycline HCl and chlorothiazide sodium.
  • •Folic acid is unstable in the presence of calcium salts such as calcium gluconate.
  • •Vitamin A and thiamine in INFUVITE ADULT may react with bisulfite solutions such as sodium bisulfite or vitamin K bisulfate.
  • •Do not add INFUVITE ADULT directly to intravenous fat emulsions.
  • •Consult appropriate references for additional listings of physical and chemical compatibility of solutions and drugs with the vitamin infusion when needed. If incompatibilities are identified, avoid admixture or Y-site administration with vitamin solutions.
  )

• •
  Pregnancy and Lactation:
  Pregnant and lactating patients should follow the U.S. Recommended Daily Allowances for their condition, because their vitamin requirements may exceed those of nonpregnant and nonlactating patients (
  8.1 Pregnancy

  Risk Summary

  Administration of the approved recommended dose of INFUVITE ADULT in parental nutrition is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. Pregnant patients should follow the U.S. Recommended Daily Allowances for pregnancy because their vitamin requirements may exceed those of nonpregnant patients. Deficiency of essential vitamins may result in adverse pregnancy outcomes

  (see Clinical Considerations)

  . Animal reproduction studies have not been conducted with INFUVITE ADULT.

  The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively.

  Clinical Considerations

  Disease-associated Maternal and/or Embryo-Fetal Risk

  Deficiency of essential vitamins has been associated with adverse pregnancy and fetal outcomes, such as maternal folic acid deficiency and an increased risk of neural tube defects. Therefore, parenteral nutrition with multiple vitamins injection should be considered if a pregnant woman’s nutritional requirements cannot be fulfilled by oral or enteral intake.
  ,
  8.2 Lactation

  Risk Summary

  Multiple vitamins present in INFUVITE ADULT are also present in human milk. Administration of the approved recommended dose of INFUVITE ADULT In parental nutrition is not expected to cause harm to a breastfed infant. There is no information on the effects of INFUVITE ADULT on milk production. Lactating patients should follow the U.S. Recommended Daily Allowances for their condition, because their vitamin requirements may exceed those of nonlactating patients. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for INFUVITE ADULT and any potential adverse effects on the breastfed child from INFUVITE ADULT or from the underlying maternal condition.
  )
• •
  Renal Impairment:
  Monitor renal function, calcium, phosphorus and vitamin A levels in patients with renal impairment (
  8.6 Renal Impairment

  INFUVITE ADULT has not been studied in patients with renal impairment. Monitor renal function, calcium, phosphorus and vitamin A levels in patients with renal impairment

  [see Warnings and Precautions ].
  )
• •
  Hepatic Impairment:
  Monitor vitamin A level in patients with liver disease, high alcohol consumption (
  8.7 Hepatic Impairment

  INFUVITE ADULT has not been studied in patients with liver impairments. Monitor vitamin A level in patients with liver disease, high alcohol consumption

  [see Warnings and Precautions ].
  )

• •
  Risk of Aluminum Toxicity:
  For at risk patients (renal failure or those with prolonged therapy), consider periodic monitoring of aluminum levels (
  5.1 Aluminum Toxicity

  INFUVITE ADULT contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solution, which contain aluminum.

  Research indicates that patients with impaired kidney function, including premature neonates who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration. To prevent aluminum toxicity periodically monitor aluminum levels with prolonged parenteral administration of INFUVITE ADULT in patients with renal impairment.
  )
• •
  Allergic Reactions:
  To thiamine may occur (
  5.2 Allergic Reactions to Thiamine

  Allergic reactions such as urticaria, shortness of breath, wheezing and angioedema have been reported following intravenous administration of thiamine, which is found in INFUVITE ADULT. There have been rare reports of anaphylactoid reactions following intravenous doses of thiamine. No fatal anaphylactoid reactions associated with INFUVITE ADULT have been reported.
  )
• •
  Hypervitaminosis A
  : Patients with renal failure or liver disease may be at higher risk (
  5.3. Hypervitaminosis A

  Hypervitaminosis A, manifested by nausea, vomiting, headache, dizziness, blurred vision has been reported in patients with renal failure receiving 1.5 mg/day retinol and in patients with liver disease, Therefore, supplementation of renal failure patients and patients with liver disease with vitamin A, an ingredient found in INFUVITE ADULT, should be undertaken with caution

  [see Use in Specific Populations ].
  )
• •
  Decreased Anticoagulant Effect of Warfarin:
  Monitor INR (
  5.4 Decreased Anticoagulant Effect of Warfarin

  INFUVITE ADULT contains Vitamin K, which may decrease the anticoagulant action of warfarin. In patients who are on warfarin anticoagulant therapy receiving INFUVITE ADULT monitor blood levels of prothrombin/INR to determine if dose of warfarin needs to be adjusted.
  ,
  7.1 Drug Interactions Affecting Co-Administered Drugs

  Warfarin

  : Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. In patients who are co-administered warfarin and INFUVITE ADULT, blood levels of prothrombin/INR should be monitored to determine if dose of warfarin needs to be adjusted

  [see Warnings and Precautions ].

  Antibiotics

  : Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease antibiotic activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin.

  Bleomycin

  : Ascorbic acid and riboflavin inactivate bleomycin

  in vitro

  , thus the activity of bleomycin may be reduced.

  Levodopa

  : Pyridoxine may increase the metabolism of levodopa (decrease blood levels of levodopa) and decrease its efficacy.

  Phenytoin:

  Folic acid may increase phenytoin metabolism and lower the serum concentration of phenytoin resulting in increased seizure activity.

  Methotrexate:

  Folic acid may decrease a patient’s response to methotrexate therapy.
  )
• •
  Interferes with Megaloblastic Anemia Diagnosis:
  Avoid during testing for this disorder (
  5.5 Interference with Diagnosis of Megaloblastic Anemia

  INFUVITE ADULT contains folic acid and cyanocobalamin which can mask serum deficiencies of folic acid and cyanocobalamin in patients with megaloblastic anemia. Avoid the use of INFUVITE ADULT in patients with suspected or diagnosed megaloblastic anemia prior to blood sampling for the detection of the folic acid and cyanocobalamin deficiencies.
  )
• •
  Risk of Vitamin Deficiencies or Excesses:
  Monitor blood vitamin concentrations (
  5.6 Potential to Develop Vitamin Deficiencies or Excesses

  In patients receiving parenteral multivitamins such as with INFUVITE ADULT, blood concentration should be periodically monitored to determine if deficiencies or excesses are developing. INFUVITE ADULT may not correct long-standing specific vitamin deficiencies. The administration of additional therapeutic doses of specific vitamins may be required

  [see Dosage and Administration ].
  )
• •
  False Negative Urine Glucose Tests:
  Due to vitamin C (
  5.7 Interference with Urine Glucose Testing

  INFUVITE ADULT contains vitamin C which is also known as ascorbic acid. Ascorbic acid in the urine may cause false negative urine glucose results.
  )